Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications prescribed for different indications: some for the management of type 2 diabetes mellitus (such as Ozempic, Victoza, Trulicity), and others specifically for weight management in adults with obesity or overweight with comorbidities (such as Wegovy, Saxenda)
Look ARG, Wing RR, Bolin P, et al
Unfamiliarity with withdrawing medication from a vial into a syringe and coupled with confusion between different units of measurement (e.g., milliliters, milligrams and units) may have contributed to dosing errors
Some medications to watch out for include: Medications for diabetes: Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL) Other oral medications : Zepbound causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time
In this study, we did not restrict either the GLP-1 treatment cohort or the control cohort to any specific medication regimen, dosage trajectory or adjunctive interventions, as the intent was to capture the full range of possible real-world medication usage that is occurring
